Multicenter prospective randomized trial comparing ceftazidime plus co-trimoxazole with chloramphenicol plus doxycycline and co-trimoxazole for treatment of severe melioidosis.

A prospective randomized trial was conducted at Srinagarind and Khon Kaen hospitals. Ceftazidime (100 mg/kg of body weight per day) and co-trimoxazole (trimethoprim, 8 mg/kg/day; sulfamethoxazole, 40 mg/kg/day) therapy was compared with conventional therapy (chloramphenicol, 100 mg/kg/day; doxycycli...

Повний опис

Бібліографічні деталі

Опубліковано в::	Antimicrob Agents Chemother
Автори:	Sookpranee, M, Boonma, P, Susaengrat, W, Bhuripanyo, K, Punyagupta, S
Формат:	Artigo
Мова:	Inglês
Опубліковано:	American Society for Microbiology (ASM) 1992
Предмети:	Research Article
Онлайн доступ:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC189245/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1590682/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.36.1.158
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!